<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000367463"><TermName>ixabepilone</TermName><TermPronunciation>(IK-suh-BEH-pih-lone)</TermPronunciation><TermDefinition><DefinitionText>A drug used to treat metastatic or locally advanced breast cancer that has not improved after treatment with certain other anticancer drugs. It is also being studied in the treatment of other types of cancer. Ixabepilone stops the growth of tumor cells by blocking cell division. It is a type of epothilone analog. Also called BMS-247550 and Ixempra.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000711224" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;ixabepilone&quot;" language="en" id="_3"/><MediaLink ref="CDR0000711225" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;ixabepilona&quot;" language="es" id="_4"/><SpanishTermName>ixabepilona</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que se usa en el tratamiento del cáncer de mama metastásico o localmente avanzado y que no ha mejorado después del tratamiento con ciertos medicamentos contra el cáncer. Está en estudio para el tratamiento de otros tipos de cáncer. La ixabepilona detiene el crecimiento de células tumorales al impedir la multiplicación celular. Es un tipo de análogo de la epotilona. También se llama BMS-247550 y Ixempra.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2004-04-23</DateFirstPublished><DateLastModified>2007-11-01</DateLastModified><RelatedInformation><RelatedDrugSummaryRef href="CDR0000573900">Ixabepilone</RelatedDrugSummaryRef></RelatedInformation></GlossaryTerm>
